Pramodini Medicare IPO GMP today is Rs 0. Investors can use this GMP along with price band and subscription status for a better IPO review.
Closed
SME IPO
PRAMODINI
Pramodini Medicare IPO GMP & Allotment
Pramodini Medicare Limited is an Indian diagnostic service provider offering a comprehensive range of technology-enabled services, including radiology, clinical laboratory testing, and nuclear medicine. The company serves public and private hospitals, government Public Sector Undertakings (PSUs), and medical colleges across tier I, II, and III cities. Its core offerings are divided into three segments: Radiology (MRI, CT scans, ultrasound), Clinical Laboratory (pathology, microbiology, immunology), and Nuclear Medicine (PET-CT and nuclear therapy). Additionally, it operates a 24×7 teleradiology service from its registered office in Vijayawada. Pramodini Medicare generates revenue by providing routine and specialized tests for prediction, early detection, and disease monitoring. The business uniquely operates across four key models: Public-Private Partnerships (PPP) with government hospitals, Private-Private Partnerships, strategic alliances with PSUs, and standalone private centres. This diversified approach enables the company to deliver widespread preventative and diagnostic healthcare solutions across India.
- IPO Price Band
- ₹110.00 - ₹118.00
- Lot Size
- 1,200 Shares
- Bidding Closes
- 14 Aug 2026
- Listing Date
- 19 Aug 2026
Quick Answer & Highlights
Pramodini Medicare IPO GMP Today & Key Takeaways
Last updated: 13 Aug 2026
The Grey Market Premium (GMP) for Pramodini Medicare IPO is currently awaiting trading updates (last quote: ₹0). The shares are offered in the price band of ₹110.00 - ₹118.00 per share, with a minimum retail investment of Rs 2,83,200 for 1,200 Shares. Public bidding has closed. The basis of allotment is expected on 17 Aug 2026, ahead of stock exchange listing on 19 Aug 2026.
The Grey Market Premium (GMP) for Pramodini Medicare IPO is currently awaiting trading updates (last quote: ₹0). The shares are offered in the price band of ₹110.00 - ₹118.00 per share, with a minimum retail investment of ₹2,83,200 for 1,200 Shares. Public bidding has closed, with allotment expected on 17 Aug 2026 and listing on 19 Aug 2026.
| Key Metric | Figure | Status / Context |
|---|---|---|
| Current GMP | ₹0 | +0% vs upper band (13 Aug 2026) |
| Est. Listing Price | Est. ₹118 | +0.00% Est. Listing Gain |
| Price Band | ₹110.00 - ₹118.00 | SME IPO |
| Retail Minimum Investment | ₹2,83,200 | 2 Lot (1,200 Shares) |
| Bidding Window | 12 Aug 2026 – 14 Aug 2026 | Closed |
| Allotment & Listing Dates | Allotment: 17 Aug 2026 | Listing: 19 Aug 2026 |
Current GMP Status
₹0
+0% vs upper band
Est. Listing Gain
+0.00%
Last Trend
13 Aug 2026
Listing Price
Est. ₹118
Retail Entry
₹2,83,200
IPO Details
Complete IPO information
| IPO Open Date | 12 Aug 2026 |
|---|---|
| IPO Close Date | 14 Aug 2026 |
| IPO Price Band | ₹110.00 - ₹118.00 |
| Lot Size | 1,200 Shares |
| Current GMP | ₹0 |
| Estimated Listing Gain | +0.00% |
| Issue Size | Approx ₹69.04 Cr |
| Fresh Issue | - |
| Issue Type | SME |
| IPO Listing | NSE, BSE |
| Retail Quota | TBA |
| Registrar | TBA |
| Overall Subscription | 3.87x |
| Minimum Investment | ₹2,83,200 |
| DRHP Draft Prospectus | - |
| RHP Draft Prospectus | - |
Demand Tracker
Subscription Status
| Category | Shares Reserved | Shares Applied | Subscription (x) |
|---|---|---|---|
| QIB | 11.71 | 42.83 | 3.66xx |
| NII | 9.6 | 47.59 | 4.96xx |
| Retail | 20.23 | 70.51 | 3.49xx |
| Overall Subscription | 41.54 | 160.93 | 3.87xx |
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Pramodini Medicare is priced at ₹118 per share. With a minimum lot size of 1,200 shares, a retail investor applying for one lot would need approximately ₹2,83,200 to participate in this SME issue.
The latest recorded Grey Market Premium for Pramodini Medicare stands at ₹0, implying an estimated listing gain of around 0.00% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
As of the latest update, Pramodini Medicare's IPO was subscribed 3.87x overall, with a category-wise breakdown of Retail 3.49x, QIB 3.66x, NII 4.96x.
Among the strengths highlighted in Pramodini Medicare's IPO documents: The business model spans PPP, private hospitals, PSUs, and standalone centres.; The diagnostic network grew from 1 centre in FY15 to 16 centres today..
Investors should also weigh the risk factors Pramodini Medicare has disclosed, including: High dependence on government PPP MOUs subject to non-renewal or delayed payments..
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
Timeline
IPO roadmap at a glance
✓
Bidding Opens
12 Aug 2026
✓
Bidding Closes
14 Aug 2026
03
Allotment Next
17 Aug 2026
04
Listing
19 Aug 2026
| Event / Milestone | Scheduled Date | Status |
|---|---|---|
| Bidding Opens | 12 Aug 2026 | Completed |
| Bidding Closes | 14 Aug 2026 | Completed |
| Allotment | 17 Aug 2026 | Next Milestone |
| Listing | 19 Aug 2026 | Pending |
Grey Market Premium
Daily GMP status
Trend chart builds up as more daily GMP snapshots are recorded.
| Date | GMP | Change | Gain |
|---|---|---|---|
| 13 Aug 2026 | ₹0.00 | - | 0.00% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 2,400 | ₹2,83,200 |
| Retail Maximum | 2 Lot | 2,400 | ₹2,83,200 |
| S-HNI Minimum | 3 Lot | 3,600 | ₹4,24,800 |
| S-HNI Maximum | 7 Lot | 8,400 | ₹9,91,200 |
| B-HNI Minimum | 8 Lot | 9,600 | ₹11,32,800 |
Swipe to see more →
Fund Utilization
Objects of the Issue & Official Documents
Issue Notes
Important takeaways before applying
Strengths
- The business model spans PPP, private hospitals, PSUs, and standalone centres.
- The diagnostic network grew from 1 centre in FY15 to 16 centres today.
- Offers specialized services across radiology, clinical laboratory, and nuclear medicine.
- Revenue grew significantly from ₹3,522.95 lakhs in FY24 to ₹6,228.75 lakhs in FY26.
- Leverages public health infrastructure through extensive government MOUs.
Risks
- High dependence on government PPP MOUs subject to non-renewal or delayed payments.
- Focus on capital-intensive radiology exposes the firm to equipment and regulatory risks.
- Over 60% revenue concentration in Andhra Pradesh creates geographic risk.
- Loss of top institutional clients could severely impair revenue and profitability.
- Past statutory filing delays and non-compliances expose the firm to regulatory penalties.
Analysis
Pramodini Medicare IPO Reservation
The Pramodini Medicare IPO has allocated shares across Anchor Investors, Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors. The reservation structure determines the number and percentage of shares available for each investor category.
Anchor investors have been allocated 13,60,800 shares, representing 23.26% of the issue. The QIB category excluding anchor investors has been allocated 11,71,200 shares, while 9,60,000 shares are available for NIIs. Retail investors have been offered 20,23,200 shares, representing 34.58% of the issue.
| Investor Category | Shares Offered | Reservation (%) |
|---|---|---|
| Anchor Investor | 13,60,800 Shares | 23.26% |
| Qualified Institutional Buyers (QIB) (Ex. Anchor) | 11,71,200 Shares | 20.02% |
| Non-Institutional Investors (NII) | 9,60,000 Shares | 16.41% |
| Retail Individual Investors (RII) | 20,23,200 Shares | 34.58% |
Note: The above table presents the category-wise IPO reservation details. Final allotment to investors will depend on the subscription received in each category and the basis of allotment finalized after the IPO closes.
Analysis
Pramodini Medicare IPO Anchor Investors
The Pramodini Medicare IPO anchor investor bidding was scheduled for August 11, 2026, one day before the public issue opened for subscription. Anchor investors form part of the institutional allocation and participate in the IPO before the issue becomes available to other investor categories.
The final anchor investor list, number of shares allocated, anchor issue size, and applicable lock-in dates can be updated once the complete anchor allocation information is available.
| Particular | Details |
|---|---|
| Anchor Bidding Date | August 11, 2026 |
| Anchor Investors List | To be Updated |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| Lock-in Period End Date – 50% Shares (30 Days) | 2026 |
| Lock-in Period End Date – Remaining 50% Shares (90 Days) | 2026 |
Note: The anchor investor names, final shares offered, anchor size, and exact 30-day and 90-day lock-in expiry dates should be updated once the final anchor allocation details are available.
Analysis
Pramodini Medicare IPO Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 12 Aug 2026 |
| IPO Close Date | 14 Aug 2026 |
| Basis of Allotment | 17 Aug 2026 |
| Refunds | - |
| Credit to Demat Account | - |
| IPO Listing Date | 19 Aug 2026 |
Note: The timeline for Pramodini Medicare IPO is tentative and subject to change.
Analysis
Pramodini Medicare IPO Promoters and Holding Pattern
The promoters of Pramodini Medicare are Dr. Chalasani Kuldeep Kumar, Dr. Chalasani Kavitha, Ms. Chalasani Durga Aashritha and M/s. Sri Ram Medicare Private Limited. Before the IPO, the promoter and promoter group collectively hold 85.71% of the company's equity share capital.
Following the IPO, the promoter and promoter group's shareholding is expected to decline to 62.64%, while the shareholding of other investors is expected to increase from 14.29% to 37.36%. The company's total equity shares are expected to increase from 1,66,94,795 shares before the IPO to 2,20,45,595 shares after the issue.
Promoters of Pramodini Medicare
- Dr. Chalasani Kuldeep Kumar
- Dr. Chalasani Kavitha
- Ms. Chalasani Durga Aashritha
- M/s. Sri Ram Medicare Private Limited
| Particular | Pre IPO Shares | Pre IPO % Shares | Post IPO Shares | Post IPO % Shares |
|---|---|---|---|---|
| Promoter and Promoter Group | 1,43,09,477 | 85.71% | 1,38,09,077 | 62.64% |
| Others* | 23,85,318 | 14.29% | 82,36,518 | 37.36% |
| Total | 1,66,94,795 | 100% | 2,20,45,595 | 100% |
Note: The above table presents the pre-IPO and proposed post-IPO shareholding pattern of Pramodini Medicare. The promoter group's holding is expected to decrease from 85.71% before the issue to 62.64% after completion of the IPO.
Analysis
Pramodini Medicare Objects of the Issue & Utilisation of Proceeds
To Be Updated Soon
Analysis
Pramodini Medicare About IPO
Pramodini Medicare Limited, founded in 2000, is one of the leading diagnostic services providers in India across radiology, clinical laboratory, and nuclear medicine segments. Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour Doppler, mammography, DEXA scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy.
Pramodini Medicare operates diagnostic centres through Public-Private Partnerships (PPP), Private-Private Partnerships (Pvt-Pvt), Strategic Partnerships with PSUs, Standalone Diagnostic Centres, and Location-Specific Agreements. The firm has its presence across Vijayawada, Hyderabad, Kurnool, Kapada, Tirupati, Varanasi, Prayagraj, and many others.
Analysis
Pramodini Medicare Company Financials
To Be Updated Soon
Analysis
Pramodini Medicare Company Valuation – FY2026
To Be Updated Soon
Analysis
Pramodini Medicare IPO Peer Group Comparison
To Be Updated Soon
Analysis
IPO Lead Managers aka Merchant Bankers
- Smart Horizon Capital Advisors Pvt.Ltd.
Comparison
Compare Pramodini Medicare IPO with similar IPOs
FAQ
Pramodini Medicare IPO FAQs
Pramodini Medicare IPO price band is Rs 110.00 to Rs 118.00. Check the latest issue price, lot size and GMP together before applying.
Pramodini Medicare IPO open date is 12 Aug 2026, close date is 14 Aug 2026, and listing date is 19 Aug 2026.
Pramodini Medicare IPO lot size is 1,200 shares. The minimum retail investment is Rs 2,83,200.
Pramodini Medicare is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
Pramodini Medicare IPO subscription status currently shows Retail 3.49x, QIB 3.66x, NII 4.96x, Overall 3.87x.
Pramodini Medicare Limited is an Indian diagnostic service provider offering a comprehensive range of technology-enabled services, including radiology, clinical laboratory testing, and nuclear medicine. The company serves public and private hospitals, government Public Sector Undertakings (PSUs), and medical colleges across tier I, II, and III cities. Its core offerings are divided into three segments: Radiology (MRI, CT scans, ultrasound), Clinical Laboratory (pathology, microbiology, immunology), and Nuclear Medicine (PET-CT and nuclear therapy). Additionally, it operates a 24×7 teleradiology service from its registered office in Vijayawada. Pramodini Medicare generates revenue by providing routine and specialized tests for prediction, early detection, and disease monitoring. The business uniquely operates across four key models: Public-Private Partnerships (PPP) with government hospitals, Private-Private Partnerships, strategic alliances with PSUs, and standalone private centres. This diversified approach enables the company to deliver widespread preventative and diagnostic healthcare solutions across India.
Pramodini Medicare IPO issue size is 69.04 and the expected allotment date is 17 Aug 2026.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
Community discussion
Comments
Share a useful question or insight about Pramodini Medicare.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Keep Exploring
Similar Recent IPOs
SME
Vedant Poly Fabs
Price Band₹88.00 - ₹94.00
Current GMP₹1 · +1.1%
Lot Size1,200 Shares
SME
Johnsoncab Electricals
Price Band₹190.00 - ₹200.00
Current GMP₹8 · +4.0%
Lot Size600 Shares
SME
HGS (India)
Price Band₹114.00 - ₹120.00
Current GMP₹28 · +23.3%
Lot Size1,200 Shares
SME
Maxwell Engineering Solutions
Price Band₹150.00 - ₹158.00
Current GMP₹142.2 · +66.5%
Lot Size800 Shares
Loading comments...